The included scripts were used in the study: Thomas F. Broekhoff, Carly C.G. Sweegers, Eline M. Krijkamp, Aukje K. Mantel-Teeuwisse, Hubert G.M. Leufkens, Wim G. Goettsch, Rick A. Vreman,
Early Cost-Effectiveness of Onasemnogene Abeparvovec-xioi (Zolgensma) and Nusinersen (Spinraza) Treatment for Spinal Muscular Atrophy I in The Netherlands With Relapse Scenarios,
Value in Health,
2021

To run the analyses, please use the scripts in the "run" folder. Other necessary scripts will be loaded when needed.